ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2003
Diagnosis and management of anaphylaxis.
Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 154 citations in OpenAlex.
- Anaphylaxis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024Review
- Article
- Ketorolac-induced anaphylaxis following oral administration: a case series.Annals of medicine and surgery (2012) · 2023Article
- Investigation on the Effect of Age and Gender on Hypersensitivity Reactions due to Allergens Injection in Iraqi Population.Archives of Razi Institute · 2022Article
- A Case Report of Prolonged Anaphylaxis after COVID-19 Vaccine.Clinical practice and cases in emergency medicine · 2022Article
- Update of the S2k guideline on the management of IgE-mediated food allergies.Allergologie select · 2021Article
- Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation.Antibodies (Basel, Switzerland) · 2020Article
- Neurologic manifestations in anaphylaxis due to subcutaneous allergy immunotherapy: A case report.Medicine · 2018Article
- Anaphylaxis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2018Review
- Outpatient Emergencies: Anaphylaxis.The Medical clinics of North America · 2017Review
- Adverse events related to blood transfusion.Indian journal of anaesthesia · 2014Review
- Acute treatment of anaphylaxis in children.Canadian family physician Medecin de famille canadien · 2013Article
- Fish-oil capsule ingestion: a case of recurrent anaphylaxis.Canadian family physician Medecin de famille canadien · 2012Article
- Anaphylaxis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2011Article
- Common causes of anaphylaxis in children: the first report of anaphylaxis registry in iran.The World Allergy Organization journal · 2010Article
- Model-based prediction of the patient-specific response to adrenaline.The open medical informatics journal · 2010Article
- Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy.World journal of surgical oncology · 2008Article
- Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report.Journal of medical case reports · 2008Article
- Navigating the updated anaphylaxis parameters.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2007Article
- Anaphylactoid shock in a patient following 5% human serum albumin infusion during off-pump coronary artery bypass grafting.Journal of anesthesia · 2007Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaphylaxis is a severe systemic allergic reaction that is potentially fatal. It requires prompt recognition and immediate management. Anaphylaxis has a rapid onset with multiple organ-system involvement and is mostly caused by specific antigens in sensitized individuals. Reactions typically follow a uniphasic course, however, 20% will be biphasic in nature. The second phase usually occurs after an asymptomatic period of 1-8 hours, but there may be a 24-hour delay. Protracted anaphylaxis may persist beyond 24 hours. Concurrent beta-blocker therapy may adversely affect the response to management. Epinephrine is the treatment of choice and should be administered immediately. Secondary measures include circulatory support, H(1) and H(2) antagonists, corticosteroids and, occasionally, bronchodilators. Post-treatment observation of these patients is necessary, and they should remain within ready access of emergency care for the following 48 hours.
Indexed as
Identifiers
12925426PMC180656W2140082814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.